TY - JOUR
T1 - Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic
AU - Cartes, Cristian
AU - Segovia, Christian
AU - Salinas-Toro, Daniela
AU - Goya, Claudia
AU - Alonso, Maria Jesus
AU - Lopez-Solis, Remigio
AU - Zapata, Claudia
AU - Cabezas, Mauricio
AU - Yañez, Patricio
AU - Flores-Rodriguez, Patricia
AU - Lopez, Daniela
AU - Matus, Gonzalo
AU - Traipe, Leonidas
N1 - Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
PY - 2022
Y1 - 2022
N2 - Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic. Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Participants were classified as having mild/moderate (7–12) or severe (>12) DE symptoms based on their DEQ-5 score. The associations between severe DE symptoms and relevant factors were also evaluated. Results: The data of 1450 eligible students were analyzed. The mean age of the participants was 21.1 (2.7) years. 42.8% of the participants had mild/moderate DE symptoms, whereas 34.7% had severe symptoms. Associated factors for severe DE were female sex (OR = 2.57, CI [1.97–3.35]), allergic disease (OR = 1.63, CI [1.24–2.13]), previous dry eye diagnosis (OR = 13.49, CI [7.10–25.63]), keratoconus (OR = 5.56, CI [1.27–24.44], contact lens use (OR = 1.77, CI [1.24–2.53]) and duration of VDT use (OR = 1.02, CI [1.01–1.05]). Prior to the pandemic, the mean reported duration of VDT use was 9.8 (4.7) hours; this increased to 15.9 (5.8) hours during the online classes (p < .001). 80.6% of the participants reported a global increase in VDT-related symptoms. Conclusion: Students taking online classes had a high frequency of DE symptoms. They also reported a significant increase in VDT-related symptoms. DE should be considered as an emerging health problem among the young population, which is probably related to the recent changes in lifestyle.
AB - Purpose: To evaluate dry eye (DE) and subjective visual display terminal (VDT)-related symptoms in university students who moved their classes online due to the COVID-19 pandemic. Methods: Cross-sectional study of students who were taking online classes. In May 2020, the participants completed a Dry Eye Questionnaire (DEQ-5) and a self-report survey, which included demographics, medical history, information on the use of VDT and presence of VDT-related symptoms. Participants were classified as having mild/moderate (7–12) or severe (>12) DE symptoms based on their DEQ-5 score. The associations between severe DE symptoms and relevant factors were also evaluated. Results: The data of 1450 eligible students were analyzed. The mean age of the participants was 21.1 (2.7) years. 42.8% of the participants had mild/moderate DE symptoms, whereas 34.7% had severe symptoms. Associated factors for severe DE were female sex (OR = 2.57, CI [1.97–3.35]), allergic disease (OR = 1.63, CI [1.24–2.13]), previous dry eye diagnosis (OR = 13.49, CI [7.10–25.63]), keratoconus (OR = 5.56, CI [1.27–24.44], contact lens use (OR = 1.77, CI [1.24–2.53]) and duration of VDT use (OR = 1.02, CI [1.01–1.05]). Prior to the pandemic, the mean reported duration of VDT use was 9.8 (4.7) hours; this increased to 15.9 (5.8) hours during the online classes (p < .001). 80.6% of the participants reported a global increase in VDT-related symptoms. Conclusion: Students taking online classes had a high frequency of DE symptoms. They also reported a significant increase in VDT-related symptoms. DE should be considered as an emerging health problem among the young population, which is probably related to the recent changes in lifestyle.
KW - COVID-19
KW - Dry eye disease
KW - students
KW - visual display terminal
UR - https://www.scopus.com/pages/publications/85110455233
U2 - 10.1080/09286586.2021.1943457
DO - 10.1080/09286586.2021.1943457
M3 - Article
C2 - 34251964
AN - SCOPUS:85110455233
SN - 0928-6586
VL - 29
SP - 245
EP - 251
JO - Ophthalmic Epidemiology
JF - Ophthalmic Epidemiology
IS - 3
ER -